688235 百济神州
已收盘 05-25 15:00:00
资讯
新帖
简况
中金：恒指季检调整后工业与医疗保健业覆盖度提升，6只股票或纳入港股通
智通财经 · 05-25 13:59
中金：恒指季检调整后工业与医疗保健业覆盖度提升，6只股票或纳入港股通
智谱、MiniMax，有望加入恒生科技指数
市场资讯 · 05-22
智谱、MiniMax，有望加入恒生科技指数
百济神州美股盘前涨超10%
每日经济新闻 · 05-20
百济神州美股盘前涨超10%
港股异动 | 百济神州(06160)涨近3% 近日索托克拉美国FDA获批 公司首季度净利超出市场预期
智通财经 · 05-20
港股异动 | 百济神州(06160)涨近3% 近日索托克拉美国FDA获批 公司首季度净利超出市场预期
生物医药板块盘初普涨 药明合联(02268)涨5.24%、百济神州(06160)涨2.17%
金吾财讯 · 05-19
生物医药板块盘初普涨 药明合联(02268)涨5.24%、百济神州(06160)涨2.17%
大行集体看涨百济神州(06160)， Q1业绩印证长期投资价值
智通财经 · 05-19
大行集体看涨百济神州(06160)， Q1业绩印证长期投资价值
5月18日百济神州跌5.09%，万家行业优选LOF基金重仓该股
证券之星 · 05-18
5月18日百济神州跌5.09%，万家行业优选LOF基金重仓该股
百济神州正在接近生命周期的一次切换
蓝鲸财经 · 05-18
百济神州正在接近生命周期的一次切换
美股中概股盘前涨跌互现，百度、阿里巴巴涨1%
每日经济新闻 · 05-18
美股中概股盘前涨跌互现，百度、阿里巴巴涨1%
百济神州(06160)：百悦达®获美国FDA批准成为美国首款且目前唯一治疗复发╱难治套细胞淋巴瘤的BCL2抑制剂
智通财经 · 05-14
百济神州(06160)：百悦达®获美国FDA批准成为美国首款且目前唯一治疗复发╱难治套细胞淋巴瘤的BCL2抑制剂
百济神州Beqalzi™ (Sonrotoclax)获美国FDA批准，成为首个且唯一用于R/R套细胞淋巴瘤的Bcl2抑制剂
美股速递 · 05-14
百济神州Beqalzi™ (Sonrotoclax)获美国FDA批准，成为首个且唯一用于R/R套细胞淋巴瘤的Bcl2抑制剂
科技仍是主战场？知名基金经理打出什么“隐形牌”
第一财经 · 05-13
科技仍是主战场？知名基金经理打出什么“隐形牌”
百济神州(06160)：授出受限制股份单位
智通财经 · 05-13
百济神州(06160)：授出受限制股份单位
中邮证券：给予百济神州买入评级
证券之星 · 05-13
中邮证券：给予百济神州买入评级
百济神州(688235)3月31日股东户数3.52万户，较上期增加6.53%
证券之星 · 05-12
百济神州(688235)3月31日股东户数3.52万户，较上期增加6.53%
百济神州一季度净利润超16亿元；今年医保谈判工作启动
21世纪经济报道 · 05-11
百济神州一季度净利润超16亿元；今年医保谈判工作启动
百济神州(06160)发布第一季度业绩 归母净利润16.08亿元 同比扭亏为盈
智通财经网 · 05-11
百济神州(06160)发布第一季度业绩 归母净利润16.08亿元 同比扭亏为盈
5月11日百济神州涨5.89%，万家行业优选LOF基金重仓该股
证券之星 · 05-11
5月11日百济神州涨5.89%，万家行业优选LOF基金重仓该股
百济神州涨5.89%，浦银国际证券二个月前给出“买入”评级，目前股价已超目标价
证券之星 · 05-11
百济神州涨5.89%，浦银国际证券二个月前给出“买入”评级，目前股价已超目标价
【机构调研记录】恒生前海基金调研百济神州
证券之星 · 05-11
【机构调研记录】恒生前海基金调研百济神州
加载更多
公司概况
公司名称：
百济神州有限公司
所属行业：
医药制造业
上市日期：
2021-12-15
主营业务：
百济神州有限公司的主营业务是研究、开发、生产以及商业化创新型药物。公司的主要产品是抗肿瘤类药物。
发行价格：
192.60
{"stockData":{"symbol":"688235","market":"SH","secType":"STK","nameCN":"百济神州","latestPrice":241.71,"timestamp":1779692400000,"preClose":244.57,"halted":0,"volume":3739727,"delay":0,"changeRate":-0.0117,"floatShares":114999999,"shares":1542000000,"eps":2.0518,"marketStatus":"已收盘","change":-2.86,"latestTime":"05-25 15:00:00","open":244.4,"high":245.25,"low":238.02,"amount":898000000,"amplitude":0.0296,"askPrice":241.71,"askSize":38,"bidPrice":241.7,"bidSize":15,"shortable":0,"etf":0,"ttmEps":2.0518,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1779759000000},"marketStatusCode":5,"adr":0,"adjPreClose":244.57,"symbolType":"stock_kcb","openAndCloseTimeList":[[1779672600000,1779679800000],[1779685200000,1779692400000]],"highLimit":269.03,"lowLimit":220.11,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":1541583805,"isCdr":false,"pbRate":11.28,"roa":"--","peRate":117.80388,"roe":"5.05%","epsLYR":1.03,"committee":-0.654762,"marketValue":372616000000,"turnoverRate":0.0325,"status":1,"afterMarket":{"amount":0,"volume":0,"close":241.71,"buyVolume":0,"sellVolume":0,"time":1779694437558,"indexStatus":"已收盘 05-25 15:30:00","preClose":244.57},"hkstockBrief":{"symbol":"06160","market":"HK","secType":"STK","nameCN":"百济神州","latestPrice":184.5,"timestamp":1779437302006,"preClose":183.1,"halted":0,"volume":4820875,"delay":0,"premium":"-33.91"},"floatMarketCap":27810000000},"requestUrl":"/m/hq/s/688235","defaultTab":"news","newsList":[{"id":"2638585985","title":"中金：恒指季检调整后工业与医疗保健业覆盖度提升，6只股票或纳入港股通","url":"https://stock-news.laohu8.com/highlight/detail?id=2638585985","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2638585985?lang=zh_cn&edition=full","pubTime":"2026-05-25 13:59","pubTimestamp":1779688785,"startTime":"0","endTime":"0","summary":"参照恒指公司的行业分类，此次恒指调整后，对于医疗保健业的覆盖度从38.8%提升至44.3%，对于工业的覆盖度从54.3%提升至56.0%。该行根据此次恒生综合指数调整情况、结合港股通纳入的额外要求，预计6只或符合港股通纳入范围。此次进入恒生综合指数的Minimax-W由于其同股不同权性质，需额外满足上市满6个月及20个交易日的条件，因此不会在本次6月调整中进入港股通，预计于8月纳入港股通。若后续满足市值与成交额要求，有望于8月纳入港股通。","market":"sh","thumbnail":"https://static.tigerbbs.com/38508134c6853c521e764dc952e7334a","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/38508134c6853c521e764dc952e7334a"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1445467.html","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1568","LU2476274720.SGD","HHImain","LU2488822045.USD","LU1770034418.SGD","03067","03423","07588","LU0348783233.USD","03037","BK1589","LU1808992512.USD","03032","07300","BK1592","LU1251922891.USD","03417","BK1574","LU0348827113.USD","03115","03033","07200","LU2778985437.USD","HSCEI","02600","HSCI","02837","LU1303224171.USD","LU0417516902.SGD","LU1719994722.HKD","02833","688235","LU0561508036.HKD","BK1161","BK1583","03692","BK1175","601600","HK0000286598.CNH","83115","03088","LU1794554557.SGD","IE00B543WZ88.USD","LU2476274308.USD","LU0417516738.SGD","09088","LU0348735423.USD","LU0634319403.HKD","02800","ONC","LU0588546209.SGD","00100","LU0348767384.USD","MCHmain","IE00BPRC5H50.USD","BK1117","07226","01519","HSI","LU1720050803.USD","IE00B5MMRT66.SGD","82828","LU0540923850.HKD","HSTECH","03419","82800","06160","LU2399975544.HKD","07288","03416","09926","07500","513600","LU0348825331.USD","LU0348784397.USD","09067","LU0348766576.USD","BK1588","BK1151","02828","BK1500","02513","LU0417516571.SGD","09115","LU0307460666.USD","BK1513","07552","LU1969619763.USD","LU2328871848.SGD","BK1191","LU1961090484.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637399348","title":"智谱、MiniMax，有望加入恒生科技指数","url":"https://stock-news.laohu8.com/highlight/detail?id=2637399348","media":"市场资讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2637399348?lang=zh_cn&edition=full","pubTime":"2026-05-22 13:38","pubTimestamp":1779428280,"startTime":"0","endTime":"0","summary":" 恒生指数公司将于今日收市后公布季度检讨结果。 市场焦点集中在智谱、MiniMax这两只AI概念股，有望被纳入恒生科技指数及综合指数。 根据市场分析，智谱、MiniMax因近期市值大幅上升，已成为纳入恒生科技指数的最有力候选。 至于摩根士丹利此前预期，智谱、及MiniMax将于6月纳入恒生科技指数，合计权重约5%至7%，或带动12.5亿至17.5亿美元的被动资金流入，而纳入港股通可能会在6个月内将内地持股比例提升至自由流通股的9%至20%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/wm/2026-05-22/doc-inhytyys6180072.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LU0417516571.SGD","09987","LU0594300419.USD","03088","IE00B5MMRT66.SGD","YUMC","BK1583","03419","BK1198","LU0540923850.HKD","LU2488822045.USD","LU0348783233.USD","07226","82800","02833","LU1794554557.SGD","09088","LU0650527681.SGD","HHImain","LU0588546209.SGD","06160","LU0823426308.USD","03423","LU1303224171.USD","LU2476274308.USD","BEKE","LU1719994722.HKD","LU0128525929.USD","LU0708994859.HKD","LU2399975544.HKD","BK1544","02513","LU1251922891.USD","LU0348767384.USD","02837","83115","03417","LU0634319403.HKD","03067","07200","MHImain","LU1969619763.USD","513600","LU1720050803.USD","688235","01818","BK1500","LU0417516902.SGD","BK1161","HSTECH","LU0307460666.USD","BK1574","LU2279701549.SGD","LU0348766576.USD","IE0034224299.USD","03115","07300","BK1097","LU0417516738.SGD","HSI","09067","ONC","MCHmain","LU2328871848.SGD","02800","03037","LU0310800379.SGD","LU0823426480.USD","LU2778985437.USD","IE00BPRC5H50.USD","09115","LU1770034418.SGD","09926","LU1961090484.USD","LU0561508036.HKD","07552","07500","LU0029864427.USD","LU0348827113.USD","BK1588","LU2476274720.SGD","BK1117","03032","BK1592","LU0348735423.USD","LU0348825331.USD","LU0348784397.USD","02423","IE00B543WZ88.USD","03033","00100","LU1267930573.SGD","BK1233","LU0228659784.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636140728","title":"百济神州美股盘前涨超10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2636140728","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2636140728?lang=zh_cn&edition=full","pubTime":"2026-05-20 16:12","pubTimestamp":1779264777,"startTime":"0","endTime":"0","summary":"百济神州美股盘前涨超10%","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202605203743484856.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202605203743484856.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU1251922891.USD","BK1583","BK4526","LU1969619763.USD","LU1719994722.HKD","LU1303224171.USD","BK4139","BK0239","BK1588","06160","LU0307460666.USD","BK4585","BK1500","LU0588546209.SGD","BK1161","BK4588","LU2328871848.SGD","688235","ONC","LU1770034418.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636145813","title":"港股异动 | 百济神州(06160)涨近3% 近日索托克拉美国FDA获批 公司首季度净利超出市场预期","url":"https://stock-news.laohu8.com/highlight/detail?id=2636145813","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2636145813?lang=zh_cn&edition=full","pubTime":"2026-05-20 13:58","pubTimestamp":1779256684,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，百济神州涨近3%，截至发稿，涨2.23%，报178.7港元，成交额4.67亿港元。此前，百济神州披露26Q1业绩，中金指出，收入15.13亿美元，同比增长35%，其中产品收入14.87亿美元，同比增长34%，GAAP净利润2.27亿美元，同比增加2.26亿美元，销售收入符合该行预期，净利润超该行预期，主因费用控制较好。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1443849.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4588","BK0239","BK4526","BK4139","LU1303224171.USD","ONC","VXUS","BK1588","688235","LU0588546209.SGD","LU1719994722.HKD","BK1500","LABU","BK4585","BK1161","LU0307460666.USD","LU1969619763.USD","LU1251922891.USD","BK1583","LU2328871848.SGD","06160","LU1770034418.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636885146","title":"生物医药板块盘初普涨 药明合联(02268)涨5.24%、百济神州(06160)涨2.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2636885146","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2636885146?lang=zh_cn&edition=full","pubTime":"2026-05-19 09:46","pubTimestamp":1779155169,"startTime":"0","endTime":"0","summary":"金吾财讯 | 港股生物医药板块盘初普涨，截至发稿，药明合联 涨5.24%，科伦博泰生物涨4.01%，百济神州涨2.17%，诺诚健华涨2.00%，药明生物涨1.58%，康诺亚-B涨1.35%，金斯瑞生物科技涨1.12%。消息面上，中邮证券研究表示，26年有望迎来BD和重点项目数据读出的双重催化，国产创新药全球性竞争力提升逻辑不断强化。建议关注确定性高、BD预期扰动相对小的标的。","market":"sh","thumbnail":"https://static.szfiu.com/news/20241108/OWU0MGRiNDM1NDA5NTM4MzU5OQ==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/OWU0MGRiNDM1NDA5NTM4MzU5OQ==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1981657","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0516422440.USD","01548","LU0417516902.SGD","LU0181495838.USD","BK1576","LU0823426308.USD","LU0039217434.USD","LU0456846285.SGD","BK4588","02269","ONC","09969","688235","LU0708995583.HKD","LU1303224171.USD","BK1574","XBI","BK1588","02268","06990","LU0348825331.USD","LU0359202008.SGD","161726","LU0320764599.SGD","LU0588546209.SGD","BK1583","LU1688375341.USD","BK4581","LU1242518931.SGD","399441","BK1141","LU0052750758.USD","LU0516422366.SGD","LU1770034418.SGD","LU1719994722.HKD","LU0417516738.SGD","IE00B0JY6N72.USD","BK1161","LU3063872942.SGD","BK1589","HK0000306701.USD","SG9999002562.SGD","HK0000320264.USD","LU1251922891.USD","LU0359201612.USD","LU0043850808.USD","06160","SG9999014674.SGD","LU0307460666.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636883343","title":"大行集体看涨百济神州(06160)，\tQ1业绩印证长期投资价值","url":"https://stock-news.laohu8.com/highlight/detail?id=2636883343","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2636883343?lang=zh_cn&edition=full","pubTime":"2026-05-19 09:10","pubTimestamp":1779153033,"startTime":"0","endTime":"0","summary":"GAAP口径下，百济神州Q1季度全球总收入达15.13亿美元，同比增长35.5%，超出此前FactSet一致预期的14.4亿美元。26Q1季度，百济神州产品收入达15亿美元，同比增长34%。该行在将百济神州维持“买入”评级的同时，将其美股目标价由430美元进一步上调至453美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1443235.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0239","BK4588","BK4526","BK1161","LU1969619763.USD","BK4139","LU1770034418.SGD","BK1588","BK4585","688235","LU0307460666.USD","LU0588546209.SGD","06160","BK1500","LU2328871848.SGD","LU1303224171.USD","LU1719994722.HKD","LU1251922891.USD","ONC","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636025578","title":"5月18日百济神州跌5.09%，万家行业优选LOF基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2636025578","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2636025578?lang=zh_cn&edition=full","pubTime":"2026-05-18 16:28","pubTimestamp":1779092926,"startTime":"0","endTime":"0","summary":"证券之星消息，5月18日百济神州跌5.09%，收盘报239.2元，换手率4.02%，成交量4.62万手，成交额11.12亿元。重仓百济神州的前十大公募基金请见下表：该股最近90天内共有8家机构给出评级，买入评级8家；过去90天内机构目标均价为321.19。根据2026基金Q1季报公募基金重仓股数据，重仓该股的公募基金共107家，其中持有数量最多的公募基金为万家基金的万家行业优选LOF。该公募基金现任基金经理为黄兴亮。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051800022970.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688235","LU1770034418.SGD","BK1500","LU1719994722.HKD","BK1161","BK1583","LU1303224171.USD","LU2328871848.SGD","LU1251922891.USD","160916","BK0239","LU0307460666.USD","LU0588546209.SGD","06160","LU1969619763.USD","BK1588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636023442","title":"百济神州正在接近生命周期的一次切换","url":"https://stock-news.laohu8.com/highlight/detail?id=2636023442","media":"蓝鲸财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2636023442?lang=zh_cn&edition=full","pubTime":"2026-05-18 16:13","pubTimestamp":1779092018,"startTime":"0","endTime":"0","summary":"文｜锦缎市场整体下跌时，百济神州再次成为资金流出的对象。BTK叙事的延伸一个常见的解读是，百济神州又增加了一款新药。从单品到矩阵的跃迁，本质上是公司生命周期的一次切换。索托克拉的获批，是百济神州在这条路径上迈出的一步。泽布替尼代表了百济神州的过去和现在。百济神州拿到了一张关键牌，但牌局远未到收官的阶段。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.lanjinger.com/d/1779076618818843533","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"lanjinger_stock","symbols":["LU1303224171.USD","BK1500","BK0239","06160","BK1583","688235","LU1770034418.SGD","BK4526","BK4585","LU0588546209.SGD","LU1719994722.HKD","LU2328871848.SGD","BK1161","LU1969619763.USD","BK4588","BK1588","ONC","BK4139","LU0307460666.USD","LU1251922891.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636702309","title":"美股中概股盘前涨跌互现，百度、阿里巴巴涨1%","url":"https://stock-news.laohu8.com/highlight/detail?id=2636702309","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2636702309?lang=zh_cn&edition=full","pubTime":"2026-05-18 16:02","pubTimestamp":1779091355,"startTime":"0","endTime":"0","summary":"5月18日，美股中概股盘前涨跌互现，百度、阿里巴巴涨1%，京东涨0.4%，拼多多持平，网易跌0.3%，百济神州跌0.8%，携程跌1%，理想汽车跌10%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202605183740446853.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202605183740446853.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK4527","LU1688375341.USD","ASHS","NTES","688235","LU0310800965.SGD","BK4531","LU0128525689.USD","MCHI","LU0348816934.USD","BK4538","LU0456842615.SGD","LU0918141887.USD","BABU","BK4554","LU1115378108.SGD","LU0949170772.SGD","LU0821914370.USD","LU1282648689.USD","LU2226246903.HKD","BIDG","BK4524","LU0640798160.USD","BK4565","82822","LU1880383366.USD","LU0553294199.USD","LU0501845795.SGD","BK4612","LU1003077747.HKD","BABW","ASHR","LU0979878070.USD","LU1242518931.SGD","XPP","LU0348814723.USD","02843","BK4552","FLCH","02822","LU0918141705.HKD","LU0963586101.USD","BK4534","09618","ALBmain","IE00BF5LJ272.USD","82843","BK4122","09988","BK4574","LU1769817096.USD","06160","LU1235294995.USD","LU1008478684.HKD","09961","LU0072913022.USD","02823","BABX","LU0359201612.USD","IE00B0JY6N72.USD","BK4504","BK4533","HXC","KBDU","BK4077","KBAB","LU1051768304.USD","BK4505","BK4550","LU0359202008.SGD","LU1023057109.AUD","LU0651947912.USD","LU0880133367.SGD","BK4514","CWEB","DRAG","LI","BK4220","LU0651946864.USD","LU1267930227.SGD","LU1046421795.USD","BABO","BK4614","BK4543","LU2148611432.USD","BBYY","BK4607","BK4588","LU0251143458.SGD","LU0738911758.USD","LU1242518857.USD","BK4502","IE00BFMHRM44.USD","LU0052756011.USD","BIDU","BK4575","LU1823568750.SGD","LU1048588211.SGD","LU1051769294.HKD","PDD","BK4585","BK4526","LU0797268264.HKD","LU1152091754.HKD","YXI","LU0067412154.USD","09999","JD","BK4581","BK4535","BK4602","BK4503","BK4548","TCOM","BK4587","LU1046422090.SGD","LU1105468828.SGD","BABA","ONC","LU0106959298.USD","LU0545039389.USD","LU1769817179.HKD","02015","LU0047713382.USD","LU0173614495.USD","09888","LU0287142896.SGD","FXP","LU1515016050.SGD","82823","LU0072462343.USD","LU1152091168.USD","LU0328353924.USD","BK4558","LU0661504455.SGD","BK4579","LU1048596156.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635936752","title":"百济神州(06160)：百悦达®获美国FDA批准成为美国首款且目前唯一治疗复发╱难治套细胞淋巴瘤的BCL2抑制剂","url":"https://stock-news.laohu8.com/highlight/detail?id=2635936752","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2635936752?lang=zh_cn&edition=full","pubTime":"2026-05-14 07:47","pubTimestamp":1778716032,"startTime":"0","endTime":"0","summary":"智通财经APP讯，百济神州 发布公告，公司于2026年5月13日宣布百悦达获得美国食品药品监督管理局加速批准，用于治疗既往接受过至少两线系统治疗的复发或难治性(R/R)套细胞淋巴瘤成人患者。索托克拉是一款在BCL2靶点研发中具有基石性潜力的新一代BCL2抑制剂，其研发设计以增强BCL2抑制剂作用为目标，在分子效力和选择性方面进行了优化，且其药理学特性也有望改善用药的有效性、耐受性和便利性。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1441483.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1588","LU1969619763.USD","BK4585","LU0588546209.SGD","LU1770034418.SGD","BK4526","688235","LU2328871848.SGD","BK4588","BK1500","BK1583","LU0307460666.USD","BK4139","LABU","LU1251922891.USD","ONC","LU1719994722.HKD","06160","BK1161","LU1303224171.USD","BK0239"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"1113457800","title":"百济神州Beqalzi™ (Sonrotoclax)获美国FDA批准，成为首个且唯一用于R/R套细胞淋巴瘤的Bcl2抑制剂","url":"https://stock-news.laohu8.com/highlight/detail?id=1113457800","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1113457800?lang=zh_cn&edition=full","pubTime":"2026-05-14 01:28","pubTimestamp":1778693292,"startTime":"0","endTime":"0","summary":"百济神州旗下药物Beqalzi™ (Sonrotoclax)已获得美国食品药品监督管理局的批准，成为首个且唯一获批用于治疗复发或难治性套细胞淋巴瘤的Bcl2抑制剂。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["688235","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635878967","title":"科技仍是主战场？知名基金经理打出什么“隐形牌”","url":"https://stock-news.laohu8.com/highlight/detail?id=2635878967","media":"第一财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2635878967?lang=zh_cn&edition=full","pubTime":"2026-05-13 20:36","pubTimestamp":1778675760,"startTime":"0","endTime":"0","summary":" 当市场还在复盘一季报时，部分机构投资者的“隐形棋”已经落子。 随着多家上市公司因股份回购等事项更新股东名单，一批知名基金经理的“隐秘”调仓路径曝光。 与此同时，机构调研热度持续升温，科技板块仍是资金关注的核心腹地。 日前，力源信息因股份回购事宜更新前十名股东及前十名无限售条件股东持股情况。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/roll/2026-05-13/doc-inhxufvi4481411.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/roll/2026-05-13/doc-inhxufvi4481411.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LU0348735423.USD","BK0132","LU0039217434.USD","LU1303224171.USD","LU0164939612.USD","IE00BYTNYN87.SGD","HK0000306685.HKD","LU0417516902.SGD","BK0148","LU2495084118.USD","002705","LU1580142542.USD","LU2476274720.SGD","BK0175","LU0634319403.HKD","LU0871576103.HKD","LU0164865239.USD","LU1934453819.USD","LU0561508036.HKD","300184","LU0531971595.HKD","300308","301498","BK0214","LU1251922891.USD","LU1770034418.SGD","002126","BK0109","LU2213484517.USD","LU2289578879.USD","LU2580892789.USD","SG9999011746.SGD","BK0028","LU0082770016.USD","IE00B12V2V27.USD","LU0348825331.USD","LU2476274308.USD","LU2778985437.USD","688235","LU1781817850.SGD","LU1997245177.USD","300502","BK0161","LU0540923850.HKD","LU2580892862.HKD","LU0417516738.SGD","LU1997244956.HKD","LU1720050803.USD","BK0167","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635202523","title":"百济神州(06160)：授出受限制股份单位","url":"https://stock-news.laohu8.com/highlight/detail?id=2635202523","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2635202523?lang=zh_cn&edition=full","pubTime":"2026-05-13 17:04","pubTimestamp":1778663056,"startTime":"0","endTime":"0","summary":"智通财经APP讯，百济神州(06160)发布公告，于2026年5月8日，董事会薪酬委员会根据2016期权及激励计划的条款向201名承授人授出涉及合共25,436股美国存托股份的受限制股份单位。该等受限制股份单位相当于330,668股股份，约占本公告之日公司发行股份总数的0.02%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1441212.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU1251922891.USD","BK1583","BK4526","LU1969619763.USD","LU1719994722.HKD","LU1303224171.USD","BK4139","BK0239","BK1588","06160","LU0307460666.USD","BK4585","BK1500","LU0588546209.SGD","BK1161","BK4588","LU2328871848.SGD","688235","ONC","LU1770034418.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635205859","title":"中邮证券：给予百济神州买入评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2635205859","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2635205859?lang=zh_cn&edition=full","pubTime":"2026-05-13 15:05","pubTimestamp":1778655925,"startTime":"0","endTime":"0","summary":"中邮证券有限责任公司盛丽华,陈灿近期对百济神州进行研究并发布了研究报告《泽布替尼同比维持高增，全年业绩指引上调》，给予百济神州买入评级。公司为创新药出海龙头企业，全球商业化能力突出、在研管线即将进入收获期，维持“买入”评级。最新盈利预测明细如下：该股最近90天内共有4家机构给出评级，买入评级4家；过去90天内机构目标均价为321.19。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051300021645.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["161027","06160","688235"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634291209","title":"百济神州(688235)3月31日股东户数3.52万户，较上期增加6.53%","url":"https://stock-news.laohu8.com/highlight/detail?id=2634291209","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2634291209?lang=zh_cn&edition=full","pubTime":"2026-05-12 17:18","pubTimestamp":1778577534,"startTime":"0","endTime":"0","summary":"证券之星消息，近日百济神州披露，截至2026年3月31日公司股东户数为3.52万户，较12月31日增加2161.0户，增幅为6.53%。在化学制药行业个股中，百济神州股东户数低于行业平均水平，截至3月31日，化学制药行业平均股东户数为3.58万户。从股价来看，2025年12月31日至2026年3月31日，百济神州区间跌幅为13.03%，在此期间股东户数增加2161.0户，增幅为6.53%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051200029275.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688235","LU0307460666.USD","LU0588546209.SGD","06160","BK1500","BK1161","LU1303224171.USD","LU1719994722.HKD","LU1251922891.USD","LU1969619763.USD","LU1770034418.SGD","LU2328871848.SGD","BK1588","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634228933","title":"百济神州一季度净利润超16亿元；今年医保谈判工作启动","url":"https://stock-news.laohu8.com/highlight/detail?id=2634228933","media":"21世纪经济报道","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2634228933?lang=zh_cn&edition=full","pubTime":"2026-05-11 20:04","pubTimestamp":1778501046,"startTime":"0","endTime":"0","summary":"政策动向今年医保谈判工作启动近日，国家医保局发布《2026年国家基本医疗保险、生育保险和工伤保险药品目录及商业健康保险创新药品目录调整工作方案》，并向社会公开征求意见。21点评：根据《征求意见稿》，今年的工作程序仍分为准备、申报、评审、谈判、公布结果5个阶段。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202605113733316580.html","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202605113733316580.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["ONC","688235","06160"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634288993","title":"百济神州(06160)发布第一季度业绩 归母净利润16.08亿元 同比扭亏为盈","url":"https://stock-news.laohu8.com/highlight/detail?id=2634288993","media":"智通财经网","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2634288993?lang=zh_cn&edition=full","pubTime":"2026-05-11 18:57","pubTimestamp":1778497043,"startTime":"0","endTime":"0","summary":"智通财经APP讯，百济神州(06160)发布2026年第一季度业绩，该集团取得营业收入105.44亿元，同比增长31.0%;归属于上市公司股东的净利润16.08亿元，同比扭亏为盈;基本每股收益1.11元。更多港股重磅资讯，下载智通财经app更多港股及海外理财资讯，请点击www.zhitongcaijing.com（搜索“智通财经”）；欲加入智通港股投资群，请加智通客服微信(ztcjkf)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1440306.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["06160","ONC","688235"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634409612","title":"5月11日百济神州涨5.89%，万家行业优选LOF基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2634409612","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2634409612?lang=zh_cn&edition=full","pubTime":"2026-05-11 16:30","pubTimestamp":1778488246,"startTime":"0","endTime":"0","summary":"证券之星消息，5月11日百济神州涨5.89%，收盘报262.08元，换手率5.41%，成交量6.23万手，成交额15.82亿元。重仓百济神州的前十大公募基金请见下表：该股最近90天内共有3家机构给出评级，买入评级3家；过去90天内机构目标均价为330.49。根据2026基金Q1季报公募基金重仓股数据，重仓该股的公募基金共107家，其中持有数量最多的公募基金为万家基金的万家行业优选LOF。万家行业优选LOF目前规模为58.28亿元，最新净值1.5479，较上一交易日下跌1.13%，近一年上涨31.77%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051100021927.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1500","LU1719994722.HKD","BK0239","LU2328871848.SGD","06160","BK1583","688235","LU1303224171.USD","BK1588","LU1251922891.USD","LU0588546209.SGD","LU1770034418.SGD","LU1969619763.USD","LU0307460666.USD","160916","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634625409","title":"百济神州涨5.89%，浦银国际证券二个月前给出“买入”评级，目前股价已超目标价","url":"https://stock-news.laohu8.com/highlight/detail?id=2634625409","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2634625409?lang=zh_cn&edition=full","pubTime":"2026-05-11 16:30","pubTimestamp":1778488238,"startTime":"0","endTime":"0","summary":"今日百济神州涨5.89%，收盘报262.08元。2026年3月9日，浦银国际证券研究员阳景,胡泽宇发布了对百济神州的研报《四季度收入符合预期，2026年催化剂丰富》，该研报对百济神州给出“买入”评级，认为其目标价为236.0元，现价已超分析师预估，涨幅达到11.05%。证券之星数据中心根据近三年发布的研报数据计算，该研报作者对此股的盈利预测准确度为9.25%。证券之星数据中心计算显示，对该股盈利预测较准的分析师团队为中信证券的甘坛焕。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051100021923.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["161027","06160","688235"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634222854","title":"【机构调研记录】恒生前海基金调研百济神州","url":"https://stock-news.laohu8.com/highlight/detail?id=2634222854","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2634222854?lang=zh_cn&edition=full","pubTime":"2026-05-11 08:03","pubTimestamp":1778457786,"startTime":"0","endTime":"0","summary":"证券之星消息，根据市场公开信息及5月8日披露的机构调研信息，恒生前海基金近期对1家上市公司进行了调研，相关名单如下：1）百济神州 调研纪要：百悦泽?恒生前海基金成立于2016年，截至目前，资产管理规模236.06亿元，排名118/212；资产管理规模236.03亿元，排名99/212；管理公募基金数69只，排名91/212；旗下公募基金经理8人，排名120/212。旗下最近一年表现最佳的公募基金产品为恒生前海高端制造混合A，最新单位净值为1.6，近一年增长141.07%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051100002319.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU1969619763.USD","LU1251922891.USD","BK1500","BK0239","BK1583","LU2328871848.SGD","BK1588","688235","06160","LU0588546209.SGD","LU1719994722.HKD","LU1770034418.SGD","LU1303224171.USD","BK1161","LU0307460666.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1779734129515,"stockEarnings":[{"period":"1week","weight":0.0105},{"period":"1month","weight":0.0292},{"period":"3month","weight":-0.1373},{"period":"6month","weight":-0.1527},{"period":"1year","weight":0.0464},{"period":"ytd","weight":-0.1001}],"compareEarnings":[{"period":"1week","weight":0.0051},{"period":"1month","weight":0.0178},{"period":"3month","weight":0.0085},{"period":"6month","weight":0.0746},{"period":"1year","weight":0.2402},{"period":"ytd","weight":0.0463}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"百济神州有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"35235人(较上一季度增加6.53%)","perCapita":"3265股","listingDate":"2021-12-15","address":"c/o BeOne Medicines I GmbH, Aeschengraben 27, 4051Basel, Switzerland","registeredCapital":"15万元","survey":" 百济神州有限公司的主营业务是研究、开发、生产以及商业化创新型药物。公司的主要产品是抗肿瘤类药物。","listedPrice":192.6},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.2","shortVersion":"4.42.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"百济神州(688235)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供百济神州(688235)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"百济神州,688235,百济神州股票,百济神州股票老虎,百济神州股票老虎国际,百济神州行情,百济神州股票行情,百济神州股价,百济神州股市,百济神州股票价格,百济神州股票交易,百济神州股票购买,百济神州股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"百济神州(688235)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供百济神州(688235)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}